Updated:
Royal Philips
Royal Philips is a corporate investor based in Amsterdam, founded 1891; the Altss profile covers its classification, headquarters, registration, AUM band, and...
General information
Firm type
Corporate Investor
Year founded
1891
Location
Region
Europe
Country
Netherlands
City
Amsterdam
Corporate office
Amstelplein 2, 1096 BC Amsterdam, Netherlands
Additional offices
Eindhoven, Netherlands
Principals
Roy Jakobs
CEO, Chairman of the Board of Management and Executive Committee
Charlotte Hanneman
CFO, Member of the Board of Management
Marnix van Ginneken
Chief ESG & Legal Officer, Chair of Philips Foundation Board
Sector focus
Frequently asked questions
Who runs investment decisions at Royal Philips?
The Executive Committee, chaired by CEO Roy Jakobs, sets the strategic direction, with R&D allocation and M&A executed at the operational level. Charlotte Hanneman has served as CFO since 2024, overseeing the balance-sheet capacity for acquisitions and internal venture funding. The Board of Management retains final authority on large transactions.
Does Royal Philips commit to external funds or only direct investments?
Philips does not operate as a traditional fund-of-funds investor. Its capital deployment is concentrated on internal R&D programs and direct acquisitions of companies in diagnostics, connected care, and health informatics. It runs a blockchain research lab and the Philips Foundation Impact Investments vehicle, but the parent company's primary investing motion is corporate M&A rather than LP commitments.
What sectors does Philips prioritize for capital deployment?
Philips concentrates its R&D and acquisition spend on diagnostic imaging, image-guided therapy, patient monitoring, ultrasound, and personal health. Within those domains, it emphasizes software, AI, and data interoperability. The firm does not invest in pure-play pharma, biotech, or health insurance, maintaining a tight focus on medical devices and health informatics.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: